Blog
Hip fractures – Avoiding the black hole of missed management opportunities
Dr Nigel Gilchrist, Canterbury District Health Board, Christchurch, New Zealand and APCO Executive Committee Member Hip fractures in old adults are common, affecting up to...
Cost-effective fracture-probability based intervention thresholds for osteoporosis – one size does not fit all countries
The number of individuals at risk for fragility fractures worldwide is predicted to increase two-fold from the 158 million it was in 2010, to 319...
Modern day Alchemy? Bisphosphonates – the Elixir of Life?
Through millennia, alchemists and dreamers have striven to formulate the elixir of immortality and have failed – dramatically, ignominiously, and sometimes tragically. It is interesting...
Charting a path for osteoporosis care in Developing countries – spotlight on Việt Nam
A Developing economy with a per-capita GDP of around $2,600 (2018 figures), Việt Nam is the 15th most populous country in the world. It has...
Speaking up for the ‘silent disease’ in the Asia Pacific
APCO round-up of World Osteoporosis Day 2020 activities Last Tuesday, October 20, 2020, members of the Asia Pacific Consortium on Osteoporosis (APCO) celebrated with...
Osteoporosis and fragility fractures – a family affair
Celebrating World Osteoporosis Day 2020 The Asia Pacific Consortium on Osteoporosis (APCO) is delighted to be celebrating World Osteoporosis Day (WOD) today (Tuesday, October...
Goal Directed Therapy in osteoporosis: a target in sight or still a pipe-dream?
“Goal Directed Therapy” (GDT) is a patient care approach designed to improve patient outcomes, and is well established following its initial introduction in critical care....
Breakable bones and genes – How can doctors utilise genes for fracture risk assessment?
More than 300 genetic variants have been discovered to be associated with osteoporosis or fracture. The magnitude of effect of these variants on fracture risk...
